share_log

Ovid Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rubric Capital Management LP(7.52%),David Rosen(7.52%)

Ovid Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Rubric Capital Management LP(7.52%),David Rosen(7.52%)

美股sec公告 ·  02/12 07:09
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息